ALK-Abelló

Danish pharmaceutical company

ALK B Nasdaq Copenhagen ISIN DK0060027142 LEI 529900SGCREUZCZ7P020
Follow ALK-Abelló Weekly email: filings, results

Financials

Reported figures only · latest: fiscal 2026 DKK · IFRS
EPS, diluted -

Source: ESEF annual reports · latest filing